Ironwood Pharmaceuticals (IRWD) Net Cash Flow (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Net Cash Flow of $5.1 million for Q1 2026, down 93.14% sequentially from $74.7 million in Q4 2025, and down 74.3% YoY from $19.9 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Net Cash Flow (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Net Cash Flow for 17 years, with the latest figure at $5.1 million in Q1 2026.
- Quarterly Net Cash Flow fell 74.3% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $112.4 million (up 965.02% YoY) and the FY2025 annual result came in at $127.2 million, up 3670.75% from the prior year.
- Net Cash Flow eased to $5.1 million in Q1 2026 per IRWD's latest filing, from $74.7 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $84.1 million in Q1 2023 and troughed at -$565.5 million in Q2 2023.
- A 5-year average of -$23.6 million and a median of $327000.0 in 2024 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow tumbled 535.3% in 2023, then jumped 22743.43% in 2025.
- Over 5 years, Net Cash Flow stood at $82.0 million in 2022, then tumbled by 123.48% to -$19.3 million in 2023, then jumped by 101.7% to $327000.0 in 2024, then surged by 22743.43% to $74.7 million in 2025, then sank by 93.14% to $5.1 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $5.1 million, $74.7 million, and $47.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 706.94 Mn | 627.81 Mn | - | 58.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.28 Mn |
| Jun 30, 2026 | 58.28 Mn |
| Mar 31, 2026 | 5.12 Mn |
| Mar 31, 2026 | 5.12 Mn |
| Dec 31, 2025 | 74.70 Mn |
| Dec 31, 2025 | 74.70 Mn |
| Sep 30, 2025 | 47.58 Mn |
| Sep 30, 2025 | 47.58 Mn |
| Jun 30, 2025 | -14.98 Mn |
| Jun 30, 2025 | -14.98 Mn |
| Mar 31, 2025 | 19.93 Mn |
| Mar 31, 2025 | 19.93 Mn |
| Dec 31, 2024 | 327,000.00 |
| Dec 31, 2024 | 327,000.00 |
| Sep 30, 2024 | -17.29 Mn |
| Sep 30, 2024 | -17.29 Mn |
| Jun 30, 2024 | -15.97 Mn |
| Jun 30, 2024 | -15.97 Mn |
| Mar 31, 2024 | 29.36 Mn |
| Mar 31, 2024 | 29.36 Mn |